Royal Bank of Canada’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $454K | Buy |
25,266
+18,470
| +272% | +$258K | ﹤0.01% | 4442 |
|
|
2026
Q1 | $64K | Sell |
6,796
-3,662
| -35% | -$40.2K | ﹤0.01% | 5359 |
|
|
2025
Q4 | $131K | Sell |
10,458
-85,483
| -89% | -$1.14M | ﹤0.01% | 5046 |
|
|
2025
Q3 | $1.37M | Buy |
95,941
+71,450
| +292% | +$979K | ﹤0.01% | 3721 |
|
|
2025
Q2 | $300K | Sell |
24,491
-371,217
| -94% | -$5.39M | ﹤0.01% | 4857 |
|
|
2025
Q1 | $8.7M | Sell |
395,708
-24,896
| -6% | -$585K | ﹤0.01% | 1852 |
|
|
2024
Q4 | $9.54M | Sell |
420,604
-42,524
| -9% | -$928K | ﹤0.01% | 1826 |
|
|
2024
Q3 | $8.41M | Sell |
463,128
-81,691
| -15% | -$1.89M | ﹤0.01% | 1893 |
|
|
2024
Q2 | $15.9M | Sell |
544,819
-1,251
| -0.2% | -$37.1K | ﹤0.01% | 1379 |
|
|
2024
Q1 | $19.4M | Sell |
546,070
-842
| -0.2% | -$33.7K | ﹤0.01% | 1271 |
|
|
2023
Q4 | $23.8M | Buy |
546,912
+80,335
| +17% | +$3.16M | 0.01% | 1183 |
|
|
2023
Q3 | $17.8M | Buy |
466,577
+62,890
| +16% | +$2.65M | ﹤0.01% | 1226 |
|
|
2023
Q2 | $16.6M | Buy |
403,687
+15,987
| +4% | +$769K | ﹤0.01% | 1258 |
|
|
2023
Q1 | $22.3M | Sell |
387,700
-19,775
| -5% | -$1.11M | 0.01% | 1079 |
|
|
2022
Q4 | $22.8M | Sell |
407,475
-21,719
| -5% | -$1.11M | 0.01% | 1076 |
|
|
2022
Q3 | $18.2M | Sell |
429,194
-4,638
| -1% | -$238K | 0.01% | 1122 |
|
|
2022
Q2 | $23.4M | Sell |
433,832
-3,655
| -0.8% | -$220K | 0.01% | 1021 |
|
|
2022
Q1 | $28.1M | Sell |
437,487
-276,765
| -39% | -$18.2M | 0.01% | 1032 |
|
|
2021
Q4 | $47.8M | Sell |
714,252
-25,386
| -3% | -$1.72M | 0.01% | 849 |
|
|
2021
Q3 | $50.7M | Sell |
739,638
-29,873
| -4% | -$2.11M | 0.01% | 748 |
|
|
2021
Q2 | $52.5M | Sell |
769,511
-40,558
| -5% | -$2.87M | 0.01% | 733 |
|
|
2021
Q1 | $56M | Sell |
810,069
-82,145
| -9% | -$5.57M | 0.02% | 642 |
|
|
2020
Q4 | $57.9M | Buy |
892,214
+4,191
| +0.5% | +$226K | 0.02% | 642 |
|
|
2020
Q3 | $41.9M | Buy |
888,023
+23,331
| +3% | +$1.11M | 0.02% | 693 |
|
|
2020
Q2 | $40.6M | Buy |
864,692
+209,557
| +32% | +$10.3M | 0.02% | 656 |
|
|
2020
Q1 | $29.3M | Sell |
655,135
-4,557
| -0.7% | -$239K | 0.01% | 709 |
|
|
2019
Q4 | $38.4M | Buy |
659,692
+83,936
| +15% | +$5M | 0.01% | 752 |
|
|
2019
Q3 | $34.6M | Buy |
575,756
+84,549
| +17% | +$5.04M | 0.01% | 754 |
|
|
2019
Q2 | $27.4M | Buy |
491,207
+119,175
| +32% | +$6.14M | 0.01% | 892 |
|
|
2019
Q1 | $20.7M | Sell |
372,032
-15,087
| -4% | -$768K | 0.01% | 1040 |
|
|
2018
Q4 | $17.5M | Sell |
387,119
-53,240
| -12% | -$2.92M | 0.01% | 1080 |
|
|
2018
Q3 | $29M | Sell |
440,359
-76,949
| -15% | -$4.78M | 0.01% | 895 |
|
|
2018
Q2 | $33.3M | Sell |
517,308
-89,390
| -15% | -$5.54M | 0.02% | 766 |
|
|
2018
Q1 | $33.6M | Sell |
606,698
-111,847
| -16% | -$5.86M | 0.02% | 759 |
|
|
2017
Q4 | $34.4M | Sell |
718,545
-248,771
| -26% | -$12.2M | 0.02% | 804 |
|
|
2017
Q3 | $48.8M | Sell |
967,316
-105,483
| -10% | -$5.42M | 0.02% | 576 |
|
|
2017
Q2 | $58.5M | Buy |
1,072,799
+188,893
| +21% | +$9.02M | 0.03% | 468 |
|
|
2017
Q1 | $37.2M | Buy |
883,906
+19,330
| +2% | +$826K | 0.02% | 663 |
|
|
2016
Q4 | $37.1M | Sell |
864,576
-244,486
| -22% | -$9.94M | 0.02% | 669 |
|
|
2016
Q3 | $45.8M | Sell |
1,109,062
-224,306
| -17% | -$9.4M | 0.03% | 549 |
|
|
2016
Q2 | $53.2M | Sell |
1,333,368
-164,752
| -11% | -$5.93M | 0.03% | 449 |
|
|
2016
Q1 | $50.5M | Sell |
1,498,120
-2,494
| -0.2% | -$77.7K | 0.03% | 453 |
|
|
2015
Q4 | $50.9M | Sell |
1,500,614
-62,016
| -4% | -$1.94M | 0.03% | 443 |
|
|
2015
Q3 | $46.5M | Sell |
1,562,630
-229,501
| -13% | -$7.18M | 0.03% | 377 |
|
|
2015
Q2 | $49.4M | Sell |
1,792,131
-49,906
| -3% | -$1.33M | 0.03% | 386 |
|
|
2015
Q1 | $46.4M | Buy |
1,842,037
+245,964
| +15% | +$5.81M | 0.03% | 420 |
|
|
2014
Q4 | $35.4M | Buy |
1,596,073
+14,390
| +0.9% | +$292K | 0.02% | 564 |
|
|
2014
Q3 | $32.1M | Buy |
1,581,683
+139,268
| +10% | +$2.77M | 0.02% | 563 |
|
|
2014
Q2 | $27.7M | Buy |
1,442,415
+7,537
| +0.5% | +$140K | 0.02% | 624 |
|
|
2014
Q1 | $27M | Buy |
1,434,878
+33,930
| +2% | +$655K | 0.02% | 608 |
|
|
2013
Q4 | $27.3M | Buy |
1,400,948
+184,207
| +15% | +$3.38M | 0.02% | 623 |
|
|
2013
Q3 | $20M | Buy |
1,216,741
+164,134
| +16% | +$2.63M | 0.02% | 733 |
|
|
2013
Q2 | $15.8M | Buy |
+1,052,607
| New | +$15.4M | 0.01% | 784 |
|
Other funds holding IART
RCMNY
PCMI
Royal Bank of Canada's IART Position: Q2 2026 in Review
Royal Bank of Canada increased its Integra LifeSciences (IART) stake by 272% in Q2 2026, buying an estimated $258K and bringing the position to 25,266 shares worth $454K. The position accounts for ﹤0.01% of the portfolio, ranked #4442.
Royal Bank of Canada first reported a position in IART in Q2 2013 and has held it in 53 quarters since. The position peaked at $58.5M in Q2 2017. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.
- Royal Bank of Canada held 25,266 shares of Integra LifeSciences worth $454K as of Q2 2026.
- Royal Bank of Canada bought 18,470 Integra LifeSciences shares in Q2 2026, an estimated $258K.
- Integra LifeSciences made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #4442 holding.
- Royal Bank of Canada first reported a position in Integra LifeSciences in Q2 2013 and has held it in 53 quarters since.
- Royal Bank of Canada's Integra LifeSciences position peaked at $58.5M in Q2 2017.
- 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.
Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.